Browse Conditions Browse Medicines

NICE publish updated guidance on gastro-oesophageal reflux disease and dyspepsia

For Heartburn, Gastro-oesophageal reflux disease and Dyspepsia

The National Institute for Health and Care Excellence (NICE) have updated their guidance on the investigation and management of gastro-oesophageal reflux disease and dyspepsia in adults.

NICE guidelines provide advice on the care and support that should be offered to people who use health and care services.

This information explains the advice about indigestion, heartburn and reflux in adults that is set out in NICE guideline 184.

This is an update of advice on indigestion that NICE produced in 2004.

The NICE guidance update covers the following key priorities for implementation
  • Referral guidance for endoscopy
  • Interventions for uninvestigated dyspepsia
  • Interventions for gastro-oesophageal reflux disease
  • Interventions for peptic ulcer disease
  • Referral to a specialist service
  • Surveillance for people with Barrett's oesophagus

NICE website
Accessed 22/10/19
Links available in External Resources

© NICE [2019]

Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management. Clinical guideline [CG184]. Published date: September 2014 Last updated: October 2019
Available from: See Link below. All rights reserved. Subject to Notice of rights
NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.

The information provided by NICE was accurate at the time this article was issued.

NICE guidance: Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management

Reporting of suspected adverse reactions

Reporting suspected adverse reactions (side effects) after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals or patients are asked to report any suspected adverse reactions via the Yellow Card Scheme at or search for MHRA Yellow Card in the Google Play or Apple App Store.

Disclaimer: This site is designed to offer information for general educational purposes only. The health information furnished on this site and the interactive responses are not intended to be professional advice and are not intended to replace personal consultation with a qualified physician, pharmacist, or other healthcare professional. We cannot provide individual medical advice. You must always seek the advice of a professional for questions related to a disease, disease symptoms, and appropriate therapeutic treatments.

About Heartburn About Gastro-oesophageal reflux disease About Dyspepsia